心源性休克患者静脉-动脉体外膜氧合支持期间的氧合管理:一项多中心回顾性队列研究
该多中心回顾性队列纳入法国14个和瑞士1个ECMO中心的139例心源性休克VA-ECMO患者,排除体外心肺复苏患者。主要终点为ECMO支持前7天的个体平均FSO2,中位值为70%[57;79]%,且低容量中心(年VA-ECMO例数<30)更倾向于维持FSO2≥70%(OR 5.04,95%CI [1.39;20.4],p=0.017)。右桡动脉PaO2均值(第1-7天)为114[92;145] mmHg,从第1天125[86;207] mmHg降至第3天97[81;133] mmHg(p<0.01),严重高氧血症(右桡动脉PaO2≥300 mmHg)发生16例(12%)。多因素分析显示年龄(OR 1.07,95%CI [1.03-1.11],p<0.001)、FSO2均值(第1-3天)(OR 1.03 [1.00-1.06],p=0.039)和右桡动脉PaO2均值(第1-3天)(OR 1.03,95%CI [1.00-1.02],p=0.023)与ICU死亡率相关。
要点
- 139例心源性休克VA-ECMO患者中,FSO2均值(第1-7天)中位值为70%[57;79]%,低容量中心(年VA-ECMO<30例)更倾向于维持FSO2≥70%(OR 5.04,95%CI [1.39;20.4],p=0.017)。
- 右桡动脉PaO2均值(第1-7天)为114[92;145] mmHg,从第1天125[86;207] mmHg降至第3天97[81;133] mmHg(p<0.01),严重高氧血症(右桡动脉PaO2≥300 mmHg)发生16例(12%)。
- PPOSTO2仅在4个中心的39例(28%)患者中测量,其均值(第1-7天)中位值为198[169;231] mmHg。
- 多因素分析显示年龄(OR 1.07,95%CI [1.03-1.11],p<0.001)、FSO2均值(第1-3天)(OR 1.03 [1.00-1.06],p=0.039)和右桡动脉PaO2均值(第1-3天)(OR 1.03,95%CI [1.00-1.02],p=0.023)与ICU死亡率独立相关。
- 排除体外心肺复苏患者,纳入2019年8月至2022年3月期间ICU转归已结束的每中心最后10例 eligible 患者。
适用人群与场景
- 接受外周VA-ECMO支持的心源性休克患者,来自法国14个和瑞士1个ECMO中心,2019年8月至2022年3月期间ICU转归已结束的每中心最后10例 eligible 患者。
- 排除体外心肺复苏患者。
诊断标准与关键阈值
- 严重高氧血症定义为右桡动脉PaO2≥300 mmHg。
- 低容量中心定义为年VA-ECMO例数<30例。
研究设计与关键结果
- 研究类型:多中心回顾性队列研究;样本量139例;中心数:法国14个和瑞士1个ECMO中心;人群:心源性休克接受外周VA-ECMO支持的患者,排除体外心肺复苏。
- 主要终点:个体平均FSO2(第1-7天)中位值为70%[57;79]%,且因中心病例量不同而异。
- 与高容量中心相比,年VA-ECMO例数<30例的中心更倾向于维持FSO2≥70%(OR 5.04,95%CI [1.39;20.4],p=0.017)。
- 右桡动脉PaO2均值(第1-7天)为114[92;145] mmHg,从第1天125[86;207] mmHg降至第3天97[81;133] mmHg(p<0.01)。
- 严重高氧血症(右桡动脉PaO2≥300 mmHg)发生16例(12%)。
- PPOSTO2(下半身氧合的替代指标)仅在4个中心的39例(28%)患者中测量,其均值(第1-7天)中位值为198[169;231] mmHg。
- 多因素分析:年龄(OR 1.07,95%CI [1.03-1.11],p<0.001)、FSO2均值(第1-3天)(OR 1.03 [1.00-1.06],p=0.039)、右桡动脉PaO2均值(第1-3天)(OR 1.03,95%CI [1.00-1.02],p=0.023)与ICU死亡率相关。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究发现VA-ECMO支持期间FSO2均值(第1-7天)中位值为70%[57;79]%,且低容量中心更倾向于维持FSO2≥70%(OR 5.04,95%CI [1.39;20.4],p=0.017)。
- PPOSTO2监测不频繁(仅28%患者测量),并发现显著高氧血症(PPOSTO2均值198[169;231] mmHg)。
- 较高的FSO2均值(第1-3天)和右桡动脉PaO2均值(第1-3天)与ICU死亡率独立相关(OR分别为1.03,p=0.039和p=0.023)。
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGOUND: Hyperoxemia is common and associated with poor outcome during veno-arterial extracorporeal membrane oxygenation (VA ECMO) support for cardiogenic shock. However, little is known about practical daily management of oxygenation. Then, we aim to describe sweep gas oxygen fraction (FSO2), postoxygenator oxygen partial pressure (PPOSTO2), inspired oxygen fraction (FIO2), and right radial arterial oxygen partial pressure (PaO2) between day 1 and day 7 of peripheral VA ECMO support. We also aim to evaluate the association between oxygenation parameters and outcome. In this retrospective multicentric study, each participating center had to report data on the last 10 eligible patients for whom the ICU stay was terminated. Patients with extracorporeal cardiopulmonary resuscitation were excluded. Primary endpoint was individual mean FSO2 during the seven first days of ECMO support (FSO2 mean (day 1-7)).
RESULTS: Between August 2019 and March 2022, 139 patients were enrolled in 14 ECMO centers in France, and one in Switzerland. Among them, the median value for FSO2 mean (day 1-7) was 70 [57; 79] % but varied according to center case volume. Compared to high volume centers, centers with less than 30 VA-ECMO runs per year were more likely to maintain FSO2 ≥ 70% (OR 5.04, CI 95% [1.39; 20.4], p = 0.017). Median value for right radial PaO2 mean (day 1-7) was 114 [92; 145] mmHg, and decreased from 125 [86; 207] mmHg at day 1, to 97 [81; 133] mmHg at day 3 (p < 0.01). Severe hyperoxemia (i.e. right radial PaO2 ≥ 300 mmHg) occurred in 16 patients (12%). PPOSTO2, a surrogate of the lower body oxygenation, was measured in only 39 patients (28%) among four centers. The median value of PPOSTO2 mean (day 1-7) value was 198 [169; 231] mmHg. By multivariate analysis, age (OR 1.07, CI95% [1.03-1.11], p < 0.001), FSO2 mean (day 1-3)(OR 1.03 [1.00-1.06], p = 0.039), and right radial PaO2 mean (day 1-3) (OR 1.03, CI95% [1.00-1.02], p = 0.023) were associated with in-ICU mortality.
CONCLUSION: In a multicentric cohort of cardiogenic shock supported by VA ECMO, the median value for FSO2 mean (day 1-7) was 70 [57; 79] %. PPOSTO2 monitoring was infrequent and revealed significant hyperoxemia. Higher FSO2 mean (day 1-3) and right radial PaO2 mean (day 1-3) were independently associated with in-ICU mortality.
参考来源
- Winiszewski H, Vieille T, Guinot PG, et al. Oxygenation management during veno-arterial ECMO support for cardiogenic shock: a multicentric retrospective cohort study. Ann Intensive Care. 2024. PMID: 38597975. doi:10.1186/s13613-024-01286-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。